The nation's largest lender State Bank of India has hit the international debt market with a benchmark issue to raise around USD 500 million as part of its USD 10-billion medium-term notes programme through a five- year dollar money sale.
The Project will support MSMEs through direct financing by the Small Industries Development Bank of India (SIDBI) and Participating Financial Institutions (PFIs) across three components.
This deal, a five year group wide supplier agreement, also marks BP's return into outsourcing and hushes all talk of the company slashing down on work with Infosys.
The anti-corruption committee in Maldives has said that no elements of corruption went into the award of the Male airport contract that was awarded to GMR for the expansion of the existing airport.
Shapoorji Pallonji one of the country's largest developers, has called off its plans to foray into the real estate private equity space, as the company has not been able to raise a corpus of USD 500 million due to a conflict of interest.
In a settlement with the US FDA at the US department of Justice, Ranbaxy has pleaded guilty to felony charges. This is a culmination of the consent degree that the company had signed in end-2011 with the US Food and Drug Administration.
Pharama analyst, Anmol Ganjoo beleives that acceptence of this felony charges will not only be sentiment negative for Ranbaxy but it will hit their brand name too.
Ranbaxy said its US arm is pleading guilty to criminal charges related to violation of the Food, Drugs and Cosmetics Act and the company. owned by Japan's Daiichi Sankyo, will now pay USD 500 million to settle all the civil, criminal lawsuits.